Photodynamic inactivation for controlling Candida albicans infections

Area of Science:

• Microbiology
• Biochemistry
• Photomedicine

Background:

• Biofilms are a major cause of persistent microbial infections, notoriously resistant to conventional antibiotics.
• Candida albicans biofilms cause significant superficial and invasive mycoses, especially in immunocompromised individuals.
• Rising antifungal resistance and drug limitations necessitate alternative therapeutic strategies.

Purpose of the Study:

• To explore the potential of Antimicrobial Photodynamic Therapy (APDT) as an alternative treatment for fungal infections.
• To investigate APDT's efficacy against biofilms, particularly those formed by Candida albicans.
• To address the limitations of current antifungal therapies, including resistance, toxicity, and narrow spectrum of action.

Main Methods:

• APDT utilizes a photosensitizer dye activated by visible light to produce reactive oxygen species (ROS).
• ROS induce oxidative stress, leading to microbial cell death.
• The study evaluates APDT's susceptibility across a range of microorganisms, with a focus on fungal biofilms.

Main Results:

• APDT has demonstrated susceptibility in a wide array of microorganisms.
• The therapy effectively targets microbial cellular components through ROS-induced oxidative processes.
• APDT shows promise as a topical antimicrobial agent for superficial and cutaneous diseases.

Conclusions:

• Antimicrobial photodynamic therapy presents a viable alternative for managing fungal infections, especially those involving biofilms.
• APDT offers an effective method for eliminating microorganisms, addressing limitations of current antifungal treatments.
• This therapy holds potential for treating superficial and cutaneous fungal diseases, improving patient outcomes.